Compounds > perindopril
Page last updated: 2024-09-02

perindopril and Cardiotoxicity

perindopril has been researched along with Cardiotoxicity in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Adamcová, M; Holečková, M; Jirkovský, E; Kollárová-Brázdová, P; Kubeš, J; Lenčová-Popelová, O; Mazurová, Y; Palička, V; Pokorná, Z; Šimůnek, T; Štěrba, M1
Aukema, HM; Austria, JA; Bortoluzzi, T; Cheung, DYC; Christie, S; Eastman, S; Eekhoudt, CR; Jassal, DS; Mittal, I; Ravandi, A; Singal, PK; Thliveris, J; Varghese, SS1
Asselin, CY; Cheung, D; Czaykowski, P; Dingman, B; Edel, A; Goyal, V; Jassal, DS; Kim, E; Mittal, I; Mozolevska, V; Ravandi, A; Schwartz, A; Shaikh, B; Singal, PK; Thliveris, J1
Das, M1

Other Studies

4 other study(ies) available for perindopril and Cardiotoxicity

ArticleYear
Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up.
    Clinical science (London, England : 1979), 2022, 01-14, Volume: 136, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antibiotics, Antineoplastic; Cardiotoxicity; Daunorubicin; Heart Diseases; Heart Failure; Male; Perindopril; Rabbits; Troponin T

2022
Comparing Flaxseed and Perindopril in the Prevention of Doxorubicin and Trastuzumab-Induced Cardiotoxicity in C57Bl/6 Mice.
    Current oncology (Toronto, Ont.), 2022, 04-21, Volume: 29, Issue:5

    Topics: Animals; Breast Neoplasms; Cardiotoxicity; Doxorubicin; Female; Flax; Humans; Mice; Mice, Inbred C57BL; Perindopril; Trastuzumab

2022
Role of renin-angiotensin system antagonists in the prevention of bevacizumab- and sunitinib-mediated cardiac dysfunction.
    American journal of physiology. Heart and circulatory physiology, 2019, 03-01, Volume: 316, Issue:3

    Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Antineoplastic Agents; Bevacizumab; Cardiotoxicity; Fumarates; Hydralazine; Male; Mice; Mice, Inbred C57BL; Perindopril; Renin-Angiotensin System; Sunitinib; Valsartan; Ventricular Dysfunction

2019
Small benefits in trastuzumab-related cardiotoxicity.
    The Lancet. Oncology, 2017, Volume: 18, Issue:1

    Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antineoplastic Agents, Immunological; Bisoprolol; Breast Neoplasms; Cardiotoxicity; Female; Humans; Perindopril; Randomized Controlled Trials as Topic; Stroke Volume; Time Factors; Trastuzumab; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling

2017